Improving cancer screening in older adults with limited life expectancy
Improving cancer screening in older adults with limited life expectancy
批准号:
9926798
负责人:
Nancy Schoenborn
金额:
$24.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-15 至 2022-05-31
关键词:
AddressAgeAreaBehaviorBreast Cancer DetectionClinical Practice GuidelineClinical TreatmentClinical TrialsClinical Trials DesignColorectalColorectal CancerCommunicationCoupledDataDecision AidDecision MakingDevelopmentDevelopment PlansElderlyElementsEnvironmentFeedbackFosteringFundingGoalsGrantHarm ReductionHealth StatusInterventionInterviewIntuitionLeadershipLearningLife ExpectancyMalignant NeoplasmsMalignant neoplasm of prostateMentorsMorbidity - disease ratePatientsPatternPhysiciansPreventive carePrimary Health CareProcessPublicationsQualitative MethodsRandomized Controlled TrialsRecommendationReportingResearchResearch MethodologyResearch PersonnelResearch ProposalsResourcesScholarshipScreening for Prostate CancerScreening for cancerStructureSurveysTestingTimeUnited States National Institutes of HealthVisitWorkbasecareercareer developmentexperiencefollow-upimplementation scienceimprovedindexinginnovationleadership developmentmalignant breast neoplasmmortalitymulti-component interventionnovelovertreatmentpatient orientedpatient screeningpoint of careprimary outcomeroutine screeningscreeningscreening guidelinesskillstherapy developmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Background: Cancer screening can lower cancer-related mortality and morbidity but may be associated with
significant harms and burdens in older adults. There is often a lag-time of 10 years before patients screened
for breast, colorectal, or prostate cancers actually benefit. On the other hand, multiple harms from screening
can occur in the short-term. Older adults with limited life expectancy continue to receive cancer screening at
high rates even though it exposes them to the harms of screening with little chance of benefit. Clinicians are a
major driver of over-screening but why they often continue to recommend cancer screening in older adults with
limited life expectancy is unknown. This proposal aims to improve the cancer screening of older adults by 1)
identifying the factors that facilitate or hinder clinician recommendations to stop routine screening in older
adults with limited life expectancy, and 2) better supporting clinicians to appropriately incorporate life
expectancy in their screening recommendations.
Research proposal: Aim 1 will use qualitative methods to understand the range of factors that facilitate or
hinder clinicians from recommending screening cessation in older adults with limited life expectancy. Aim 2 will
test these factors in a national physician survey to determine and quantify their effects on physicians'
screening recommendations in older adults with limited life expectancy. Aim 3 will then develop and pilot test a
novel multi-modal intervention to target the factors that significantly contribute to over-screening. The
intervention will be developed with input from clinicians and older adults and will use multiple, overlapping
strategies that may include decision support, communication coaching, and clinician feedback.
Career development plan: The candidate is a geriatrician who has already demonstrated national and
institutional leadership in research and a strong track record of academic scholarship with numerous high
impact publications and early investigator grants. Her long-term career goal is to be a research leader focused
on incorporating life expectancy to inform patient-centered, individualized preventive care decisions for older
adults. She has laid out a comprehensive, feasible career development plan that will enable her to transition
into an independent investigator and research leader. She proposes to learn new skills in decision support,
clinical trial design, and implementation science, in addition to continued development of leadership skills. She
has assembled an exemplary mentoring team with expertise in the subject area and the relevant research
methods and works in a rich research environment with tremendous resources to support her development.
Summary: The proposal addresses an important research gap and produces a novel intervention that may
have major impact to improve the cancer screening of older adults. The results from this proposal will support a
subsequent large-scale clinical trial to test the intervention. This proposal will also further foster the career
development of the candidate into a research leader focused on individualized preventive care in older adults.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Messaging Strategies to Reduce Breast Cancer Over-Screening in Older Women
-
批准号:10592067
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Stakeholder Engagement Core
-
批准号:10491897
-
项目类别:
-
资助金额:$21.33万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Messaging Strategies to Reduce Breast Cancer Over-Screening in Older Women
-
批准号:10382428
-
项目类别:
-
资助金额:$48.97万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Messaging Strategies to Reduce Breast Cancer Over-Screening in Older Women
-
批准号:10617181
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Stakeholder Engagement Core
-
批准号:10274372
-
项目类别:
-
资助金额:$21.43万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Stakeholder Engagement Core
-
批准号:10678971
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Messaging Strategies to Reduce Breast Cancer Over-Screening in Older Women
-
批准号:10206384
-
项目类别:
-
资助金额:$51.83万
-
财政年份:2021
-
负责人:Nancy Schoenborn
-
依托单位:
Improving cancer screening in older adults with limited life expectancy
-
批准号:10161680
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2018
-
负责人:Nancy Schoenborn
-
依托单位:
Understanding Older Adults' Perspectives on How to Incorporate Life Expectancy in Cancer Screening
-
批准号:8958982
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2015
-
负责人:Nancy Schoenborn
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: